(S)-tert-Butyl 3-propylpiperazine-1-carboxylate hydrochloride

Catalog No. :
ACMPRT347
CAS No. :
1217448-65-1
Molecular Formula :
C12H25ClN2O2
Molecular Weight :
264.80

IUPAC Name:tert-butyl (S)-3-propylpiperazine-1-carboxylate hydrochloride

(S)-tert-Butyl 3-propylpiperazine-1-carboxylate hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$394.00Login to see priceInquiryInquiry
250mg98%$776.00Login to see priceInquiryInquiry
1g98%$1223.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-tert-Butyl 3-propylpiperazine-1-carboxylate hydrochloride
IUPAC Nametert-butyl (S)-3-propylpiperazine-1-carboxylate hydrochloride
MDL No.MFCD11101276
Molecular FormulaC12H25ClN2O2
Molecular Weight264.80
SMILESO=C(N1C[C@H](CCC)NCC1)OC(C)(C)C.[H]Cl
InChI KeySTAKNWUZSICGDX-PPHPATTJSA-N
Synonym(S)-4-N-BOC-2-PROPYLPIPERAZINE-HCl;(S)-tert-Butyl 3-propylpiperazine-1-carboxylate hydrochloride;tert-butyl (3S)-3-propylpiperazine-1-carboxylate;tert-Butyl (3S)-3-propylpiperazine-1-carboxylate hydrochloride;(S)-1-Boc-3-propyl-piperazine hydrochloride
CAS No.1217448-65-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACMPRT347 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMPRT347 route product structure diagram
    ACMPRT3471217448-65-1
Inquiry

2. ACMPRT347 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMPRT347 route product structure diagram
    ACMPRT3471217448-65-1
Inquiry

Comments (0)